Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy. NYT > Health
Tag: Lilly
Novo Nordisk and Eli Lilly rival soars 32% after promising weight loss drug results
Zealand Pharma’s Phase 2 trial was an “uniquivocal win” for a drug that can treat both liver disease and obesity, analysts said. International: Top News And Analysis